NewsCase.com Financial Intelligence
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks
Menu
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks

Search NewsCase

HomePharma & Biotech

Pharma & Biotech

  • AI & Quantum Computing
  • Analysis
  • Anime
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds

    Novo Nordisk’s Krone-Sized Question: Can Buybacks Outweigh a Broken Pipeline Narrative?

    Analysis August 31, 2026

    Evotec’s Two-Speed Recovery: Core Business Accelerates While Partnership Revenue Stalls

    Analysis August 29, 2026

    Novo Nordisk’s Multi-Front Defense: Lawsuits, Buybacks, and a Split Decision on Wall Street

    Analysis August 29, 2026

    Bayer’s Two-Speed Recovery: Operating Gains Mask a Thinner Bottom Line as Pharma Pipeline Takes Center Stage

    DAX August 29, 2026

    Novo Nordisk’s Contradictory Signals: A Downgrade, a Buyback, and a Race Against Lilly

    Asian Markets August 28, 2026

    BioNTech’s Sympathy Surge Masks a Structural Squeeze

    Healthcare August 28, 2026

    BioNTech’s September Gauntlet: Pipeline Promises Meet a Persistent Legal Shadow

    Analysis August 26, 2026

    Sellas Life Sciences Clears Legal Hurdle With 3D Medicines While All Eyes Stay Fixed on the REGAL Countdown

    Pharma & Biotech August 26, 2026
    1...8910...106Page 9 of 106

    About NewsCase

    Professional financial news and analysis for active traders and investors. We cover global markets, stocks, cryptocurrencies, and investment strategies with in-depth research and real-time market data.

    Recent News

    • Take-Two's GTA VI Demand Signal Looks Loud — Its Earnings Path Is the Quieter Story
    • IonQ's 2.8% Slide, Vanguard's 5.21% Filing and a $7.5 Million Air Force Check: Reading the Signals Correctly
    • Micron's $61.5 Billion Forecast Meets a Market Still Fretting Over AI Bills
    • AppLovin Rises Again, but Analysts' Slashed Targets and a Looming Court Deadline Tell a More Complicated Story
    • Lenovo's Boardroom Share Adjustment, a $2 Billion Refinancing, and a Shrinking PC Footprint

    Categories

    • AI & Quantum Computing
    • Analysis
    • Banking & Insurance
    • Defense & Aerospace

    Company Info

    DNV Media GmbH

    Bornheimer Str. 180
    53119 Bonn, Germany
    Phone: +49 (0) 228 28627461
    Email: info@newscase.com

    Privacy Policy Terms of Service Imprint Disclaimer Contact

    © 2026 NewsCase.com · DNV Media GmbH